Open Access Repository
Platinum versus non-platinum chemotherapy regimens for small cell lung cancer (Review)
Downloads
Downloads per month over past year
![]() |
PDF
Amarasena_Cochr...pdf | Request a copy Full text restricted Available under University of Tasmania Standard License. |
Abstract
A comparison of platinum-based and non-platinum-based chemotherapy regimens for the treatment of small cell lung cancer
Small cell lung cancer (SCLC) is a very aggressive form of cancer due to early metastasis. As a result, chemotherapy forms the mainstay of treatment. This review compared platinum-based chemotherapy regimens and non-platinum-based chemotherapy regimens for the treatment of SCLC. The results show that there is no significant difference between platinum-based and non-platinum-based chemotherapy regimens in terms of survival and overall (complete and partial) tumour response. However, platinum-based regimens did have better complete tumour response rates. Platinum-based regimens also had higher levels of nausea and vomiting, anaemia and thrombocytopenia toxicity. Further research into the quality of life associated with these treatment regimens is needed.
Item Type: | Article |
---|---|
Authors/Creators: | Amarasena, IU and Walters, JAE and Wood-Baker, R and Fong, K |
Journal or Publication Title: | Cochrane Database of Systematic Reviews 2008 |
ISSN: | 1469-493X |
DOI / ID Number: | 10.1002/14651858.CD006849.pub2 |
Additional Information: | The definitive published version is available online at: http://interscience.wiley.com |
Item Statistics: | View statistics for this item |
Actions (login required)
![]() |
Item Control Page |